Search results for "prognostic"

showing 10 items of 316 documents

Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients.

2011

We have previously identified sole +9, 13q- or 20q-, as 'favorable' and sole +8 or complex karyotype as 'unfavorable' cytogenetic abnormalities in primary myelofibrosis (PMF). In this study of 433 PMF patients, we describe additional sole abnormalities with favorable (chromosome 1 translocations/duplications) or unfavorable (-7/7q-) prognosis and also show that other sole or two abnormalities that do not include i(17q), -5/5q-, 12p-, inv(3) or 11q23 rearrangement are prognostically aligned with normal karyotype, which is prognostically favorable. These findings were incorporated into a refined two-tired cytogenetic-risk stratification: unfavorable and favorable karyotype. The respective 5-y…

AdultMaleRiskCancer Researchmedicine.medical_specialtyPathologyAdolescentChromosomal translocationmyelofibrosisGastroenterologycytogeneticsDisease-Free SurvivalSettore MED/15 - Malattie Del SangueInternal medicineComplex KaryotypemedicineHumansMyelofibrosisAgedAged 80 and overChromosome AberrationsLeukemiaHematologyPlatelet Countbusiness.industryHazard ratioKaryotypeHematologyMiddle AgedPrognosismedicine.diseaseConfidence intervalkaryotypeOncologyPrimary MyelofibrosisInternational Prognostic Scoring SystemKaryotypingOriginal ArticleFemalemyeloproliferativebusiness
researchProduct

A complication risk score to evaluate clinical severity of thalassaemia syndromes

2020

The thalassaemia syndromes (TS) show different phenotype severity. Developing a reliable, practical and global tool to determine disease severity and tailor treatment would be of great value. Overall, 7910 patients were analysed with the aim of constructing a complication risk score (CoRS) to evaluate the probability of developing one or more complications. Nine independent variables were included in the investigation as predictors. Logistic regression models were used for Group A [transfusion-dependent thalassaemia (TDT)], Group B [transfused non-TDT (NTDT)] and Group C (non-transfused NTDT). Statistically significant predictors included age (years), haemoglobin levels, hepatic transaminas…

AdultMalemedicine.medical_specialtyAdolescentcomplicationsthalassaemiacomplicationrisk scoreLogistic regressionSeverity of Illness IndexGroup AGroup BHemoglobinsYoung Adult03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicineHumansprognostic modelBlood TransfusionClinical severityHemoglobinFramingham Risk ScoreEjection fractionReceiver operating characteristicbusiness.industryHematologyMiddle AgedPrognosisChelation TherapyThalassemia ...ROC Curve030220 oncology & carcinogenesisThalassemiaFemalecomplications; prognostic model; risk score; thalassaemiaComplicationbusiness030215 immunologyBritish Journal of Haematology
researchProduct

Soluble intercellular adhesion molecule-1 (s-ICAM-1/s-CD54) in diffuse large B-cell lymphoma: association with clinical characteristics and outcome

2003

Background: High serum levels of soluble intercellular adhesion molecule-1(s-ICAM-1/s-CD54) have been associated with adverse clinical features and poor outcome in chronic lymphocytic leukemia, Hodgkin’s disease and non-Hodgkin’s lymphoma, but their value in the different subtypes of non-Hodgkin’s lymphoma has not been well addressed. Patients and methods: Our aim was to study the serum levels of s-ICAM-1 in diffuse large B-cell lymphoma (DLBCL) and to correlate them with clinical characteristics and outcome. We analyzed the serum levels of s-ICAM-1 in a series of 55 patients with DLBCL diagnosed in a single institution. s-ICAM-1 levels were quantified by an immunoenzymatic assay. Median ag…

AdultMalemedicine.medical_specialtyPathologyLymphoma B-CellChronic lymphocytic leukemiaGastroenterologyImmunoenzyme TechniquesInternational Prognostic IndexRisk Factorshemic and lymphatic diseasesInternal medicineAntineoplastic Combined Chemotherapy ProtocolsBiomarkers TumormedicineHumansSurvival analysisAgedAged 80 and overL-Lactate DehydrogenaseBeta-2 microglobulinbusiness.industryLymphoma Non-HodgkinLarge-cell lymphomaHematologyMiddle AgedIntercellular Adhesion Molecule-1Prognosismedicine.diseaseSurvival AnalysisLymphomaTreatment OutcomeOncologyB symptomsCase-Control StudiesLymphatic MetastasisDisease ProgressionFemaleLymphoma Large B-Cell Diffusemedicine.symptombusinessDiffuse large B-cell lymphomaAnnals of Oncology
researchProduct

One-year follow-up of panic disorder. Outcome and prognostic factors.

1988

A 1-year follow-up study was carried out in 77 patients with panic attacks (panic disorder). Of these patients 43% were remitted; avoidance behaviour and chronic anxiety were more persistent than panic attacks within the 1-year period. The main predictor for features of anxiety in the follow-up was avoidance behaviour. The most prominent prognostic factor for features of depression was the history of previous depressive episodes. Female patients had a poorer outcome than male patients.

AdultMalemedicine.medical_specialtyPrognostic factorOne year follow upChronic anxietybehavioral disciplines and activitiesSex Factorsmental disordersFemale patientmedicineHumansPsychiatryDepression (differential diagnoses)Depressive DisorderGeneral NeurosciencePanic disorderPanicFearmedicine.diseasePrognosisAnxiety DisordersPanicAntidepressive AgentsHospitalizationPsychotherapyPsychiatry and Mental healthNeuropsychology and Physiological PsychologyOutcome and Process Assessment Health CareAnti-Anxiety AgentsChronic DiseaseAnxietyFemalemedicine.symptomPsychologyFollow-Up StudiesEuropean archives of psychiatry and neurological sciences
researchProduct

Transfusion-dependency at presentation and its acquisition in the first year of diagnosis are both equally detrimental for survival in primary myelof…

2010

The International Prognostic Scoring System (IPSS) and karyotype are useful tools for risk stratification in primary myelofibrosis (PMF). We examined the additional prognostic impact of red blood cell transfusion need among 254 consecutive patients (median age, 59 years). Sixty-two patients ( approximately 24%) required transfusions at diagnosis whereas 22 ( approximately 9%) became transfusion-dependent and 170 remained transfusion-independent during the first year postdiagnosis; after a median follow-up of 55 months, the respective median survivals were 35, 25, and 117 months (P < 0.01). Multivariable analysis confirmed the IPSS- and karyotype-independent prognostic weight of transfusion …

AdultMalemedicine.medical_specialtytransfusion myelofibrosisPROGNOSISmedicine.medical_treatmentmyelofibrosisHematopoietic stem cell transplantationSeverity of Illness IndexSettore MED/15 - Malattie Del SangueRisk FactorsInternal medicineSeverity of illnessmedicineHumansMyelofibrosisSurvival analysisAgedRetrospective StudiesAged 80 and overChromosome AberrationsHematologybusiness.industryPatient SelectionMyelodysplastic syndromesHematopoietic Stem Cell TransplantationRetrospective cohort studyHematologyMiddle Agedmedicine.diseaseSurvival AnalysisSurgeryPrimary MyelofibrosisInternational Prognostic Scoring SystemRBC transfusiion; myelofibrosis; PROGNOSISFemaleErythrocyte TransfusionbusinessFollow-Up StudiesRBC transfusiionAmerican Journal of Hematology
researchProduct

Evidence-Based Practice Needs Stronger Prognostic Scores for the Prediction of Recurrent Stroke

2010

To the Editor: The article by Weimer et al1 is of great interest for internists and neurologists that have to prognostically stratify patients with acute or subacute cerebrovascular disease based on risk scores. However, we have to comprehend the actual and pragmatic value of the study findings for clinical practice. We previously underscored the …

Advanced and Specialized Nursingmedicine.medical_specialtySettore MED/09 - Medicina InternaEvidence-based practicebusiness.industryEvidence-based practicestrokeSettore MED/45 - Scienze Infermieristiche Generali Cliniche E Pediatricheprognostic scoreEvidence-based practice; prognostic score; stroke;Clinical PracticeRecurrent strokePhysical therapymedicineSettore MED/26 - NeurologiaNeurology (clinical)Cardiology and Cardiovascular MedicineIntensive care medicinebusinessValue (mathematics)Stroke
researchProduct

Can the Multidimensional Prognostic Index Improve the Identification of Older Hospitalized Patients with COVID-19 Likely to Benefit from Mechanical V…

2022

Objective: Data on prognostic tools for indicating mechanical ventilation in older people with COVID-19 are still limited. The aim of this research was to evaluate if the Multidimensional Prognostic Index (MPI), based on the Comprehensive Geriatric Assessment (CGA), may help physicians in identifying older hospitalized patients affected by COVID-19 who might benefit from mechanical ventilation.Design: Longitudinal, multicenter study.Settings and Participants: 502 older people hospitalized for COVID-19 in 10 European hospitals.Methods: MPI was calculated using 8 different domains typical of the CGA. A propensity score, Cox's regression analysis was used for assessing the impact of mechanical…

Aged 80 and overHealth PolicyCOVID-19HumansProspective StudiesGeneral MedicineCOVID-19 Comprehensive Geriatric Assessment Multidimensional Prognostic Index mechanical ventilation mortalitynoninvasive ventilation prognosisGeriatrics and GerontologyPrognosisGeriatric AssessmentRespiration ArtificialGeneral NursingAgedJournal of the American Medical Directors Association
researchProduct

Validation of Abbreviated Form of the Multidimensional Prognostic Index (MPI): The BRIEF-MPI Project

2022

Alberto Cella,1 Nicola Veronese,2 Carlo Custodero,3 Alberto Castagna,4 Lisa A Cammalleri,1 Walter M Capitano,2 Luisa Solimando,2 Luca Carruba,2 Carlo Sabbà,3 Giovanni Ruotolo,4 Mario Barbagallo,2 Alberto Pilotto1,3 1Department of Geriatric Care, Orthogeriatrics and Rehabilitation, E.O. Ospedali Galliera, Genova, Italy; 2Geriatric Unit, Department of Internal Medicine and Geriatrics, University of Palermo, Palermo, Italy; 3Department of Interdisciplinary Medicine, University of Bari “Aldo Moro”, Bari, Italy; 4Geriatrics Unit, “Pugliese Ciaccio” Hospital, Catanzaro, ItalyCorrespondence: Alberto Pilotto, Via delle Mura Capuccine, 14, Genova, 16128, Italy, Tel +39 010 5634400, Fax +39 …

Aged 80 and overMaleFrailtyComorbidityGeneral MedicinePrognosisClinical Interventions in AgingActivities of Daily Livingagreement frailty multidimensional prognostic index screeningHumansFemaleGeriatrics and GerontologyGeriatric AssessmentAgedClinical Interventions in Aging
researchProduct

Mortality attributable to COVID-19 in nursing home residents: a retrospective study

2021

AbstractAimCoronavirus-19 disease (COVID-19) is a widespread condition in nursing home (NH). It is not known whether COVID-19 is associated with a higher risk of death than residents without COVID-19. Therefore, the aim of this study was to assess whether COVID-19 is associated with a higher mortality rate in NH residents, considering frailty status assessed with the Multidimensional Prognostic Index (MPI).MethodsIn this retrospective study, made in 31 NHs in Venice, Italy, the presence of COVID-19 was ascertained with a nasopharyngeal swab. Frailty was evaluated using the MPI, modified according to the tools commonly used in our NHs. A Cox’s regression analysis was used reporting the resul…

AgingDiseaseCOVID-19 · Nursing home · Prognosis · Multidimensional prognostic index · Frailty comprehensive geriatric assessmen03 medical and health sciences0302 clinical medicineMultidimensional prognostic indexHumansMedicineFrailty comprehensive geriatric assessment030212 general & internal medicineMortalityGeriatric AssessmentAgedRetrospective StudiesAged 80 and overNursing homeSARS-CoV-2business.industryIncidence (epidemiology)Mortality rateConfoundingHazard ratioCOVID-19Retrospective cohort studyPrognosisConfidence intervalNursing HomesItalyPropensity score matchingOriginal ArticleFemaleGeriatrics and Gerontologybusiness030217 neurology & neurosurgeryDemography
researchProduct

Development and validation of prediction model to estimate 10-year risk of all-cause mortality using modern statistical learning methods: a large pop…

2021

Abstract Background In increasingly ageing populations, there is an emergent need to develop a robust prediction model for estimating an individual absolute risk for all-cause mortality, so that relevant assessments and interventions can be targeted appropriately. The objective of the study was to derive, evaluate and validate (internally and externally) a risk prediction model allowing rapid estimations of an absolute risk of all-cause mortality in the following 10 years. Methods For the model development, data came from English Longitudinal Study of Ageing study, which comprised 9154 population-representative individuals aged 50–75 years, 1240 (13.5%) of whom died during the 10-year follo…

AgingLongitudinal studySurvivalEpidemiologyCalibration (statistics)PopulationHealth InformaticsFeature selectionAbsolute riskPopulation-based longitudinal studyPrognostic factorsRisk AssessmentSensitivity and Specificity01 natural sciencesCohort Studies010104 statistics & probability03 medical and health sciences0302 clinical medicineStatisticsHumansMedicineLongitudinal Studies030212 general & internal medicineMortality0101 mathematicseducationAgedProportional Hazards Modelslcsh:R5-920education.field_of_studyProportional hazards modelbusiness.industryAbsolute risk reductionHealth and Retirement StudyStatistical learninglcsh:Medicine (General)businessResearch ArticleCohort studyBMC Medical Research Methodology
researchProduct